Bis(thiosemicarbazonato) Cu-64 Complexes for Positron Emission Tomography Imaging of Alzheimer's Disease

被引:68
|
作者
Fodero-Tavoletti, Michelle T. [2 ,3 ,4 ]
Villemagne, Victor L. [1 ,2 ,4 ]
Paterson, Brett M. [3 ,5 ]
White, Anthony R. [2 ,4 ,6 ]
Li, Qiao-Xin [2 ,4 ]
Camakaris, James [7 ]
O'Keefe, Graeme J. [1 ]
Cappai, Roberto [2 ,3 ]
Barnham, Kevin J. [2 ,3 ,4 ]
Donnelly, Paul S. [3 ,5 ]
机构
[1] Austin Hlth, Ctr PET, Dept Nucl Med, Heidelberg, Vic 3010, Australia
[2] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
[3] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia
[4] Mental Hlth Res Inst, Melbourne, Vic, Australia
[5] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia
[6] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia
[7] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia
基金
澳大利亚研究理事会; 英国医学研究理事会;
关键词
Alzheimer's disease; copper homeostasis; copper radiopharmaceuticals; diagnostic imaging; positron emission tomography (PET); AMYLOID-BETA-PEPTIDE; A-BETA; IN-VITRO; COPPER; BINDING; MECHANISMS; OLIGOMERS; BRAIN; ZINC; MICE;
D O I
10.3233/JAD-2010-1359
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A bis (thiosemicarbazonato) complex radiolabeled with positron emitting Cu-64 can be used for a new and alternative method for the non-invasive diagnosis of Alzheimer's disease using positron emission tomography (PET). Most imaging agents being investigated for the diagnosis of Alzheimer's disease target amyloid-beta plaque burden but our new approach highlights altered copper homeostasis. This approach has the potential to offer complementary information to other diagnostic procedures that elucidate plaque burden.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 50 条
  • [31] Preparation of Cu-64 labeled analogs of phthalocyanine-based photosensitizers for positron emission tomography (PET) imaging and in vivo studies of phthalocyanine biodistribution
    Elena, Ranyuk R.
    Nicole, Cauchon
    Hasrat, Ali
    Brigitte, Guerin
    van Lier, Johan E.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S129 - S129
  • [32] Imaging HER-2 positive breast cancer xenografts with positron emission tomography (PET) and Cu-64 labelled bifunctional chelates.
    Yapp, Donald
    Ferreira, Cara
    Crisp, Sarah
    Sutherland, Brent
    Gleave, Martin
    Bensimon, Corrine
    Jurek, Paul
    Kiefer, Gary
    CANCER RESEARCH, 2009, 69
  • [33] Integrated Positron Emission Tomography/Magnetic Resonance Imaging in clinical diagnosis of Alzheimer's disease
    Gao, Feng
    EUROPEAN JOURNAL OF RADIOLOGY, 2021, 145
  • [34] The role of positron emission tomography in the diagnosis of Alzheimer's disease - Response
    Gill, SS
    Rochon, PA
    Guttman, M
    Laupacis, A
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (03) : 468 - 469
  • [35] The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
    Jagust, William J.
    Bandy, Dan
    Chen, Kewei
    Foster, Norman L.
    Landau, Susan M.
    Mathis, Chester A.
    Price, Julie C.
    Reiman, Eric M.
    Skovronsky, Daniel
    Koeppe, Robert A.
    ALZHEIMERS & DEMENTIA, 2010, 6 (03) : 221 - 229
  • [36] Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia
    Mielke, R
    Heiss, WD
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1998, (53): : 237 - 250
  • [37] Neuroimaging of Alzheimer' s disease (AD) with Positron Emission Tomography (PET)
    Brust, P.
    Barthel, H.
    Sabri, O.
    JOURNAL OF NEUROCHEMISTRY, 2013, 125 : 41 - 41
  • [38] Positron emission tomography in Alzheimer's disease: early prediction and differentiation
    Mistur, Rachel
    Mosconi, Lisa
    De Santi, Susan
    Li, Yi
    Tsui, Wai
    de Leon, Mony
    FUTURE NEUROLOGY, 2009, 4 (01) : 23 - 38
  • [39] Amyloid-Beta Positron Emission Tomography Imaging of Alzheimer's Pathology in Parkinson's Disease Dementia
    Akhtar, Rizwan S.
    Xie, Sharon X.
    Brennan, Laura
    Pontecorvo, Michael J.
    Hurtig, Howard I.
    Trojanowski, John Q.
    Weintraub, Daniel
    Siderowf, Andrew D.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2016, 3 (04): : 367 - 375
  • [40] Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease
    Kadir, Ahmadul
    Marutle, Amelia
    Gonzalez, Daniel
    Scholl, Michael
    Almkvist, Ove
    Mousavi, Malahat
    Mustafiz, Tamanna
    Darreh-Shori, Taher
    Nennesmo, Inger
    Nordberg, Agneta
    BRAIN, 2011, 134 : 301 - 317